Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne
Acquiring Company
Gemini BioProducts
Acquired Company
Bio-Techne Corporation
West SacramentoMinneapolisManufacturingBiotechnologyManufacturingBiotechnologyHealth CareScience And EngineeringBiotechnology ResearchDescription
Gemini Bioproducts, LLC, a leading supplier of cell culture reagents and process liquids, has acquired selected fetal bovine serum (FBS) product rights and inventory from Bio-Techne. With this acquisition, GeminiBio aims to ensure continuity of supply for existing customers and provide expanded options and enhanced supply chain security for FBS products.
Quick answer
Gemini BioProducts is acquiring Bio-Techne Corporation, announced November 25, 2024. Gemini BioProducts is based in West Sacramento, California, United States.
- How much did Gemini BioProducts pay for Bio-Techne Corporation?
- The deal value was not disclosed.
- What does Gemini BioProducts do?
- Founded in 1985, GeminiBio serves the global biotechnology industry, from basic research to commercial production, with a focus on helping our customers accelerate the development of life enhancing biotherapeutics by..
- Where are Gemini BioProducts and Bio-Techne Corporation based?
- Gemini BioProducts is based in West Sacramento, California, United States. Bio-Techne Corporation is based in Minneapolis, Minnesota, United States.
- Who are the decision-makers at Gemini BioProducts?
- Fundz holds 2 contacts at Gemini BioProducts. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Science And Engineering and Biotechnology Research
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- Eton Pharmaceuticals completes acquisition of Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. to advance treatment for Wilson Disease (January 5, 2025)
- OraSure Technologies completes acquisition of Sherlock Biosciences, Inc. to expand its innovation pipeline in molecular testing market (December 19, 2024)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
- H.B. Fuller Company signs agreements to acquire Medifill Ltd. and GEM S.r.l. to expand its Medical Adhesive Technologies business (December 2, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
Who to call at Gemini BioProducts, and when
When Gemini BioProducts changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Gemini BioProducts raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gemini BioProducts, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gemini BioProducts. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gemini BioProducts makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Bio-Techne Corporation?
Bio-Techne Corporation was acquired by Gemini BioProducts, based in West Sacramento. The deal was reported on November 25, 2024. Gemini BioProducts is privately held and operates in Manufacturing.
When did Gemini BioProducts acquire Bio-Techne Corporation?
Gemini BioProducts's acquisition of Bio-Techne Corporation was reported on November 25, 2024. Gemini Bioproducts, LLC, a leading supplier of cell culture reagents and process liquids, has acquired selected fetal bovine serum (FBS) product rights and inventory from Bio-Techne. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bio-Techne Corporation do?
Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. It is publicly traded (TECH), operating in Manufacturing, and is based in Minneapolis.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.